Introduction
WAS is an X-linked immunodeficiency-cum-autoimmunity disorder arising from mutations in WAS that encodes WASp, whose deficiency in hematopoietic cells results in the human disease. 1 WASp polymerizes actin in the cytoplasm via ARP2/3-complex and reprograms RNA polymerase II-dependent transcription in the nucleus via its effect on MLL-and SWI/SNF-dependent chromatin-remodeling of gene-promoters. [2] [3] [4] Like human-WASp, other nucleation-promoting factors (NPFs) of the WASp-family, WAVE1, WASH, JMY, and N-WASp also support transcription or other nuclear functions in different organisms. [5] [6] [7] [8] [9] [10] [11] Accordingly, the classical cytoplasmic-NPFs are emerging as key players in the nucleus in roles that are mechanistically distinct from that in the cytosol. How then is the compartment-delimited role enabled for these dual-compartment, dual-function NPFs? For WASp, its cytosolic effect on ARP2/3-mediated actin polymerization is enabled by allosteric activation, wherein association with CDC42-GTP or Fyn-mediated tyrosine phosphorylation switches WASp conformation from auto-inhibitory to active. 12, 13 This structural change facilitates dimerization/oligomerization of WASp, which optimizes ARP2/3-activation and cytosolic F-actin nucleation. 14 In contrast, the co-transcriptional activity of human-WASp or Xenopus-WAVE1 does not seem to critically depend on ARP2/3 or the VCA-domain. 5, 15 Accordingly, the regulatory inputs, including unique post-translational modifications (PTM), involved in instructing the transcriptional-output of WASp-family proteins remain elusive, clarification of which we propose is central to understanding the differential effect of WASp on immunity versus autoimmunity/autoinflammation.
Given the substantial evidence for the involvement of SUMOylation in transcriptional regulation, [16] [17] [18] [19] we asked whether this PTM, not heretofore reported for any WASp-family members, enables the transcriptional role of WASp. Testing a SUMOylation-linked hypothesis is tempting because: 1) WASp associates with RanBP2, 15 an E3-SUMO-ligase, 20 raising the For personal use only. on . by guest www.bloodjournal.org From 5 possibility that RanBP2 might also SUMO-modify WASp, 2) SUMOylation impacts subcellular localization and protein-protein interactions on chromatin, 19, 21 events that could modulate WASp's role as a transcriptional-cofactor, and 3) Because SUMOylation targets entire groups of physically-interacting proteins, 19 raises the possibility that nuclear-WASp could be SUMOylated as part of collective SUMOylation of transregulatory factors (RBBP5, STAT1, NF-κB), nucleoporin (NUP358/RanBP2), or actin-myosin complex (actin, MYL12A, MYL6, ARP2/3), all proteins known to associate with WASp 3,4,15 and be SUMO-modified [21] [22] [23] [24] [25] [26] .
In SUMOylation, a small ubiquitin-related modifier (SUMO)1, 2 or 3 covalently attaches to the lysine(K)-residue contained within a SUMO-consensus, ψ KxE/D, or phospho-SUMOylconsensus, ψ KxExxS/T (ψ, hydrophobic-residue; x, any residue; D, aspartic-acid; E, glutamicacid) in a multi-step reaction involving E1-activating (SAE1/2), E2-conjugating (UBC9), and E3-ligating (RanBP2; PIAS) enzymes1. 7, 18, 26 SUMOylation, which typically modifies only a small fraction of the substrate (~10%), is reversible through the effects of multiple SUMO-specific proteases (SENPs). Substrates can be modified by one SUMO at one K-residue (monoSUMOylation), one SUMO at multiple K-residues (multi-monoSUMOylation), or form oligomeric SUMO-chain at one or multiple K-residues (polySUMOylation). Both SUMO1 and SUMO2/3 can catalyze oligomeric SUMO-chains invivo, 20, 26, 27 which fulfill multiple signaling functions including transcriptional-regulation and genome-organization. 28 Accordingly, SUMOylation of transcription factors has been linked to either gene-activation or gene-repression in both yeast and mammalian cells 29, 30 via mechanisms that include altering chromatindynamics. 16, 31, 32 For PPAR-γ and Ikaros that function either as a transcriptional-coactivator orcorepressor, this switch in transcriptional-output is effected by SUMOylation. 33, 34 Beyond serving as a simple on-off switch, SUMOylation can also fine-tune gene-expression as demonstrated for the nuclear receptor SF-1, 35 a paradigm that is relevant to testing whether WASp-SUMOylation ChIP-qPCR and RT-PCR. ChIP-assays were performed with MNase-digested chromatin derived from NEM-treated and -nontreated T H -cells as described 3, 4, 15 using antibodies/reagents shown in supplemental of SUMO-enzymes involved in E1-activation (SAE1/2), E2-conjugation (UBC9), and E3-ligation (RanBP2) were recovered from cytosolic-and nuclear-WASp complexes, whereas, those of other SUMO-enzymes (PIAS1-4, NSE2, MAPL, PC2, HDAC4, TOPORs) were not (Fig. 1a, supplemental Fig. 1 ). The WASp:SUMO-enzyme association yielded by MS was validated by reciprocal, sequential co-immunoprecipitation, which showed that WASp:RanBP2-complex associates with SUMO1 but not SUMO2/3 in T H 1-cells (Fig. 1b) . The collective presence of these SUMO-enzymes raises the possibility that WASp is SUMO-modified. (Fig. 2c) . SUMO*WASp-conjugates are first captured at 4hr in cytosol and 8hr in nucleus upon T H 1-skewing (supplemental Fig. 2a ).
WASp is
Besides unmodified-WASp (~65kD), multiple slower-migrating forms (>85kD) were captured in 1 1 the nuclear fraction of T H 1-and T H 17-cells (Fig. 2c) . For reactions that did not include NEM, additional, slower-migrating WASp-bands were undetected, upholding that these additional bands are SUMO*WASp-conjugates. Cytosolic fraction, which lacked the chain-like patterning seen in the nucleus, displayed two prominent bands at ~130kD and >300kD in NEM-treated cells (Fig.   2c ), sizes that correspond to WASp-dimer/oligomer.
14 Because NEM also inhibits deubiquitinases, it is possible that some of these slowermigrating bands could represent hybrid SUMO-Ubiquitin chains (~30kD heavier; SUMO:~20kD, Ub:~10kD), especially given the co-operative roles of ubiquitin/SUMO dual-modification in nuclear functions. 39 Significantly, RNAi-mediated SUMO1-knockdown, which does not impair 
WASp contains SUMO-consensus and SUMO-interaction motif (SIM). GPS-SUMO
algorithm 37 predicted SUMO-acceptor K-residues in all WASp-domains, although, most occurred in WH1-and Basic-domains (Fig. 3a) . Some of these K-residues occurred in the non-classical SUMO-consensus configurations previously identified in the global-mapping of SUMOylationsites. 40 These are S*motif-1, 75-ψKDxxxxSY-83, a variant of phospho:SUMOyl-consensus (ψKxDxxSx) and S*motif-2, 142-D/ExKψ-145, an inverted SUMO-consensus (Fig. 3b) . In both S*motifs, K-residues (K76, K144) and ψ -residues (V75, I145,) are conserved through evolution and are in-frame with the SUMO-consensus (ψKxD/E). In phospho:SUMOyl-consensus, K76-residue is preceded by four evolutionarily-conserved, hydrophobic(ψ) amino-acids (75-VFCV-72), known as hydrophobic-cluster-SUMOylation-motif (HCSM) and followed by Ser82 (+6 position) (Fig. 3b) . Accordingly, WASp contains target-sequences for both SUMOylation and SUMO-interaction, the functional significance of which is implied in the clustering of diseasecausing mutations (~44 patients reported) within these sites (Fig. 3c ).
Lysine-residues K66, K76, K144, K147, K235 and hydrophobic-residue V75 are important for WASp-SUMOylation invivo. To test if the predicted K-residues are SUMO-targets, we generated K>R deletion/substitution-mutants with FLAG/MYC dual-tag, stably-expressed in HeLa, and immunoprecipitated WASp-mutants with anti-FLAG antibody for invitro SUMOylation (supplemental Fig. 3 ). FL-WASp (wild-type) co-incubated with recombinant SUMO1, E1/E2-enzymes, and ATP revealed multiple slower-migrating WASp-forms (~85kD to ~220kD), which is consistent with SUMO-modification (multi-monoSUMOylation or polySUMOylation cannot be distinguished). In contrast, K>R single-mutants demonstrated that K76, K144, and K147 residues are more critical than K66 or K235 for invitro SUMOylation based on the intensity of SUMO-modified forms (Fig. 3d) . Notably, K235R results were mixed, displaying both preserved and partially compromised SUMO*WASp-conjugates in separate assays ( Fig. 3d ).
To verify the above findings invivo, normal T H-cells were stably transfected with FLAG-MYC-tagged FL-WASp or five K>R mutants with comparable expression (Fig. 3e ). After T H 1-skewing/TCR-activation and NEM-treatment, nuclear/cytosolic fractions were examined by Western blot. Transfected FL-WASp (FL-wt) gave multiple slower-migrating bands in the nucleus that corresponded with those of SUMO1 (~85-220kD) (Fig. 3f ). This implies that transfected FL- WASp is SUMOylated by endogenous SUMO-enzymes, and the heavier bands are consequent to post-translational modification rather than alternative splicing. Although neither K>R singlemutant showed complete abrogation of SUMOylation, some gradation of SUMOylation defect was observed, wherein one or more slower-migrating form(s) was lost in nuclear and/or cytosolic fractions. This indicates alternative usage of various K-residues for SUMOylation. We, therefore, generated a penta-SUMO-site mutant (PSM: lacking all five K-residues) (supplemental Fig. 3c ), which we show abrogates WASp-SUMOylation, invitro and invivo (Figs. 3d, f) , implying that these lysines are required for WASp-SUMOylation.
In sequential coIP-assays, PSM-mutant does not bind SAE2 and UBC9 establishing that failed WASp-SUMOylation is consequent to impaired interaction of PSM-mutant with SUMOenzymes (Fig. 3g) . Although PSM-mutant does not associate with SUMO1, its association with ubiquitin is unaffected (Fig. 3g) , implying that the deleted K-residues are SUMO-specific. This finding complies with the paradigm that only about one-quarter of SUMOylation sites are also ubiquitinated in the human proteome. 41 It is possible, however, that some of these K-residues upon SUMOylation may become targets of ubiquitination, acetylation, or methylation. Notably, PSMmutant binds importin-β1 and CRM1, and translocates to the T H 1-cell nucleus (Fig. 3h ) assuming the same DAPI-dim distribution as normal-WASp (supplemental Fig. 4 ), 3 implying that SUMOylation and nuclear import are not linked events for WASp, as they are for actin. 25 We next examined V75M, one of three disease-causing mutations occurring in HCSM (72- (Fig. 3c) , and find that while the monoSUMOylated-WASp*S1 form (~85kD) is present in the nucleus, multiple high molecular-weight WASp*SUMO-conjugates >85kD) are deficient, suggesting a selective defect in SUMO-chain (or SUMO:Ubiquitin-chain)
formation, a finding captured also in K76R-and K235R-mutants (Fig. 3f) . Unexpectedly, unmodified form (~65kD) of V75M and K235R WASp-mutants is also deficient in the nucleus.
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From 1 4 Why this might occur is unclear, although similar finding was reported for another polySUMOylation-deficient mutant of yeast SMT3 (hSUMO1-homolog). 28 Co-IP demonstrates that although the binding of SAE2 to the V75M-mutant is unaffected that of UBC9 is lost, which is consistent with the paradigm that S*motifs are bound by UBC9. 43 Finding that mutation of either lysine-or hydrophobic-residue perturbs WASp-SUMOylation lend further support to the functionality of S*motif-1. Significantly, in contrast to V75-and K76-residue mutations, other disease-causing mutations involving S24-, T45-, R86-, and K476-residues, although stably expressed (Fig. 3e) , do not impair WASp-SUMOylation (Fig. 3f ). This implies that not all pathogenic WAS mutations disrupt WASp-SUMOylation.
SUMOylation-deficient WASp favors COMMD1 recruitment to destabilize NF-κB at gene promoters in T H 1-cells. Because SUMO-chain modification of both endogenous and transfected
WASp is prominent in the nucleus and because SUMO-chains are linked to chromatin-signaling functions of its substrates, 27, 28 we sought to clarify its contribution to WASp's role as a cotranscriptional factor. We focused on NF-κB-signaling because of its relevance to T H 1-differentiation 44 and also because we previously showed that WASp-deficiency impairs NF-κB-activity in T H -cells. 4 EMSA-assays demonstrate that in PSM-expressing T H 1-cells, DNA-binding activity of NF-κB and its downstream effector Octamer(OCT)-proteins 45 are both diminished compared to that in T H -cells expressing FL-WASp (Fig. 4a) . DNA-binding activity of CTCF is unaffected, which denotes specificity of WASp*SUMO-effect on chromatin-signaling.
To explicate the mechanism underlying impaired NF-κB:DNA-binding activity, we asked whether COMMD1, an inhibitor of NF-κB-signaling at the DNA-level, 46, 47 associates with COMMD1 and NF-κB(p65) (Fig. 4c) . Invivo, sequential ChIP-assays showed increased co-enrichment of COMMD1 with SUMOylation-deficient mutants compared to FLWASp at IFNG-promoter in T H 1-cells (Fig. 4d) . This finding was also captured at promoters of other WASp-target genes, STAT1 and TLR1, but not TNFAIP2 or CSF2, both WASp non-target genes (Fig. 5a, no-Tx panel) . Accordingly, single-ChIP showed decreased promoter-enrichment of NF-κB(p65) in T H 1-cells expressing SUMOylation-deficient WASp, which is consistent with COMMD1's function of removing NF-κB from DNA. 46, 47 Increased COMMD1 and decreased p65 enrichment at IFNG-promoter was also captured in normal T H 1-cells depleted of endogenous-SUMO1 by RNA-interference (Fig. 5b) as well as in normal T H 0-cells (Fig. 5c) , where endogenous-WASp is nonSUMOylated and nonnuclear (Fig. 2c) . These findings propose a chromatin-signaling function for WASp*SUMO1 in p65-dependent IFNG-activation during T H 0-to-T H 1 differentiation (Fig. 5d ).
SUMOylation-deficient WASp favors HDAC6 recruitment and hypoacetylation of histone
H3-Lysine14 at p300-marked promoters of NF-κB-response genes. Because histone acetyltransferase p300 regulates NF-κB-dependent gene-activation 48, 49 including via impacting COMMD1 47 and HDAC6
50
, we wondered whether a concomitant defect of p300 contributes to the NF-κB-defect linked to nonSUMOylatable-WASp. Employing sequential-coimmunoprecipitation, we show that endogenous WASp:SUMO1:p300-complex(es) nucleated in primary T H 1-cells does not contain HDAC6 (Fig. 4b) , suggesting that SUMOylatable-WASp associates with co-activator HAT-activity. In contrast, SUMOylation-deficient WASp binds HDAC6 (Fig. 4c) , suggesting its ectopic association with co-repressor HDAC-activity. 50 Furthermore, sequential-ChIP assays 1 6 showed HDAC6 co-enriched with p300 at IFNG-promoter in PSM or V75M but not in FL-WASpexpressing T H 1-cells, where this co-association was nominal (Fig. 4d) . Similar findings were captured also at STAT1 and TLR1 promoters (Fig. 5a , non-treated HAT/HDAC-panel). Notably, promoter enrichment of p300 is unaffected (Fig. 4d) , suggesting that WASp-SUMOylation status does not impact p300 recruitment/retention but rather its functional output, activation versus repression.
We next asked if the aberrant chromatin enrichment of HDAC6 impairs p300 HATfunction of acetylating H3-lysine14 required for transcriptional-activation. 51 Sequential-ChIP shows that increased HDAC6 enrichment occurs contemporaneously with decreased enrichment of acetylated-H3K14 at IFNG, STAT1, and TLR1 promoters in PSM-and V75M-expressing T H 1-cells (Figs. 4d, 5a ). Increased HDAC6 and decreased H3K14ac enrichment at IFNG-promoter was also captured in primary T H 1-cells depleted of SUMO1 by RNA-interference (Fig. 5b) and in normal T H 0-cells (Fig. 5c) . Because promoter occupancy/activity of NF-κB is attenuated by histoneH3 hypo-/de-acetylation 52 , together our data suggest that for certain NF-κB-response genes, HDAC6-mediated attenuation of the p300 HAT-activity 50 may contribute to NF-κB-destabilization at chromatin in T H 1-cells expressing SUMOylation-deficient WASp (Fig. 5d) .
SUMOylation-deficient WASp favors ectopic activation of pro-inflammatory genes while
impeding activation of genes patterning T H 1-immunity. RT-PCR-based transcriptome profiling was used to broadly assess the effects of WASp-SUMOylation on the functional modulation of NF-κB-response genes (n=84) (Fig 6a, supplemental Fig. 5 ). Compared to FL-WASp, SUMOylation-deficient mutants showed decreased expression of most NF-κB-response genes (n=80) in T H 1-cells. These genes fall into 4 gene-ontology (GO) categories: 1) cytokines/chemokines, 2) cell survival/proliferation, 3) transcription, and 4) signal-transduction.
For
Whereas, mRNA and protein expressions of IFNG, a T H 1-cytokine, is decreased that of proinflammatory cytokines GM-CSF 53 and TNFAIP2 54 is paradoxically increased ( Fig. 6 ; non-Tx panel). Similarly, expression of pro-inflammatory cytokine IL-1β (proIL-1β or matureIL-1β cannot be distinguished) is increased (Fig. 6b , non-Tx panel) but without a concomitant mRNA increase (Fig. 6a) (Figs. 6b, 7) . In contrast, upregulation of T H 17-genes is unaffected in T H 17-skewed cells expressing SUMOylation-deficient WASp (Fig. 7) . These finding imply that WASp-SUMOylation is necessary not only for activation of T H 1-immunity but also for checking ectopic activation of pro-inflammatory pathways that destabilizes T H 1-specification.
Pan-histone deacetylase inhibitors (pHDACi) restore misregulated gene expression imposed
by SUMOylation-deficient WASp. Because NF-κB-activity is down-modulated by HDAC1, 2, 3, 6, 58-60 and because pHDACi was shown to displace HDAC6 61, 62 and relieve p300
transcriptional-repression, 50 we tested the hypothesis that pHDACi may be sufficient to neutralize COMMD1-and HDAC6-mediated transcriptional-repression imposed by SUMOylation-deficient and Na-Butyrate) and their mRNA levels quantified in the RT-PCR-based NF-κB-array. T H 1-cells expressing normal-WASp showed that about 2/3 rd of NF-κB-response genes were neither up-nor down-regulated (>2.0 fold) by pHDACi (supplemental Fig. 5c ; blue-shaded column), which agrees with prior reports demonstrating that <20% of genes become misregulated by pHDACi treatment. 63, 64 Of the genes downregulated by pHDACi in normal T H 1-cells, most belonged to "cell survival/proliferation" and "chemokines/cytokines" GO-categories, with CSF3 and CCL2 demonstrating marked suppression by pHDACi. In T H 1-cells expressing SUMOylation-deficient WASp, however, pHDACi-treatment displayed more dramatic switch in mRNA-expression patterns compared to their non-treated controls. Specifically, pHDACi restored to normal (or increased) mRNA-expression of most NF-κB-response genes, and correspondingly also of some tested proteins, which were deficient in non-treated controls (Fig. 6, supplemental Fig. 5 ).
Interestingly, pHDACi-treatment normalized (or decreased) the expression of multiple proinflammatory factors (GM-CSF, TNFAIP2, IL-1β, IL17A) that were aberrantly increased in nontreated controls (Fig. 6, supplemental Fig. 5c ), a finding that aligns with the known inhibitory effect of pHDACi on pro-inflammatory cytokine-signaling.
63
pHDACi reverses promoter transrepression imposed by SUMOylation-deficient WASp.
Because pHDACi functions in the nucleus to either deacetylase histone tails or evict HDACcontaining co-repressors from gene-promoters, 62,65,66 we asked if the salutary effect of pHDACi on misregulated transcription is consequent to these epigenetic modes of actions. First, we show that the dose and duration of pHDACi-treatment is sufficient to augment promoter enrichment of acetylated-H3K14 in FL-WASp-expressing T H 1-cells by ChIP (Fig. 5a, histoneH3 pHDACi-treatment at IFNG, STAT1, and TLR1 promoters (Fig. 5a , HAT/HDAC-column).
Contemporaneously, promoter-occupancy of NF-κB is increased but that of its inhibitor COMMD1 is decreased by pHDACi (Fig. 5a , NF-κB-column), implying that acetylated-H3K14 stabilizes NF-κB on gene-promoters in T H 1-cells, a paradigm that was previously established in HeLa and SIRT6 murine-model. 52 Conversely, neither HDAC6 nor COMMD1 are enriched at CSF2 and TNFAIP2 promoters, which could explain the chromatin "licensing" for its ectopic (Fig. 5d) . Implicit in this model is the idea that WASp participates in the process that controls the exchange between co-activator and co-repressor occupancy at target loci, and that (Fig. 3c) . 72 Whether these mutations similarly disrupt WASp-SUMOylation to imbue proinflammatory qualities to T H 1-deficient cells remains to be determined. We do, however, show that not all disease-causing mutations that result in XLT-to-WAS progression (e.g., missense mutations of S24, T45, and R86 residues that do not reside in SUMO-or SIM-motifs) impair
WASp-SUMOylation and yet impede gene activation, latter via a SWI/SNF-linked mechanism. 4 In contrast, V75M impairs WASp-SUMOylation but does not disrupt SWI/SNF promoter-activity (Fig. 4d) . Whereas, the SWI/SNF-disrupting T45M-mutation that phenocopies V75M clinically (XLT-to-WAS progression) does not display ectopic enrichment of HDAC6 or COMMD1 at IFNG-promoter observed with V75M, and yet impairs NF-κB enrichment (supplemental Fig. 6 ).
These observations imply that pathogenic-mutations have differing proclivity to disrupt different steps of transcription along the DNA-translational axis. Because we show that loss of WASp phenocopies nonSUMOylatable-WASp in causing T H 1-immunity/inflammation imbalance, our findings are relevant also for some patient T-cells lacking WASp-expression.
Interestingly, of the disease-causing mutations that do impair WASp-SUMOylation (missense-mutations of V75-, K76-, and K476-residues), not all display identical SUMOylation defect. Mutations of V75-and K76-residues both impair polySUMO-chains without affecting monoSUMOylation, a defect sufficient to recruit co-repressors (COMMD1, HDAC6) at promoters of NF-κB-response genes that are also H3K14-hypoacetylated. Certainly, besides HDAC6 and COMMD1, other HDAC-containing co-repressors, 70 may also contribute to the "repressive" chromatin-signaling module associated with deficient polySUMO-chain modification of WASp.
We also cannot exclude the possibility that V75M besides disrupting SUMOylation may introduce conformational defects, which may contribute to altered function. At the minimum, our findings linking a selective SUMO-chain defect to aberrant gene repression suggests that polySUMOmodification support a specific chromatin-signaling function distinct from that of monoSUMOmodification of WASp. Although the causality of this association remains speculative, emerging evidence linking polySUMO-chain defects to impaired chromatin-to-nucleolar targeting and DNA-instability, 73 altered chromatin-organization and transcriptional-repression, 28 and
Alzheimer's disease 74 together propose a physiologically-relevant role for WASp polySUMOchains in immunity.
Future challenges in the WASp-SUMO field will be to determine: 1) what fraction of these polymeric-chains comprises SUMO-Ubiquitin hybrid versus SUMO or ubiquitin alone, and how their loss impairs function, 2) effect of WASp-SUMOylation on immunological synapse formation, 3) how WASp-SUMOylation influences regulatory-networks controlling immunity/inflammation balance in health and disease. The latter is topical because many causalvariants in autoimmune diseases map to NF-κB-consensus motifs in T H -cell genome, 75 and
SUMOylation-deficient WASp, we show, disturbs this NF-κB:DNA-interaction.
Notwithstanding, our identification of HDACi-mediated correction of gene misregulation in SUMOylation-impaired WASp T H -cells offers chromatin-alteration using panHDAC-inhibitors (or HDAC6-inhibitor) as a new target for individualized therapy to restore immunodeficiency and attenuate autoimmunity in WAS patients, as previously entertained.
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